References
- Noth I, Strek ME, Leff AR. Churg–Strauss syndrome. Lancet 2003;361:587–94.
- Zhang W, Zhou G, Shi Q, Zhang X, Zeng XF, Zhang FC. Clinical analysis of nervous system involvement in ANCA-associated systemic vasculitides. Clin Exp Rheumatol 2009;27:S65–9.
- Stojanovich L. Autonomic dysfunction in autoimmune rheumatic disease. Autoimmun Rev 2009;8:569–72.
- Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, The American College of Rheumatology 1990 criteria for the classification of Churg–Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990;33:1094–100.
- Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. Q J Med 1994;87:671–8.
- Crawford MH, Bernstein SJ, Deedwania PC, DiMarco JP, Ferrick KJ, Garson A Jr, ACC/AHA guidelines for ambulatory electrocardiography: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee to revise the guidelines for ambulatory electrocardiography). Circulation 1999;100:886–93.
- Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 1996;93:1043–65.
- Pomeranz B, Macaulay RJ, Caudill MA, Kutz I, Adam D, Gordon D, Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol 1985;248:H151–3.
- Akselrod S, Gordon D, Ubel FA, Shannon DC, Berger AC, Cohen RJ. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science 1981;213:220–2.
- Lown B, Verrier RL. Neural activity and ventricular fibrillation. N Engl J Med 1976;294:1165–70.
- Dekker JM, Crow RS, Folsom AR, Hannan PJ, Liao D, Swenne CA, Low heart rate variability in a 2-minute rhythm strip predicts risk of coronary heart disease and mortality from several causes: the ARIC Study. Atherosclerosis Risk In Communities. Circulation 2000;102:1239–44.
- Knockaert DC. Cardiac involvement in systemic inflammatory diseases. Eur Heart J 2007;28:1797–804.
- Dennert RM, van Paassen P, Schalla S, Kuznetsova T, Alzand BS, Staessen JA, Cardiac involvement in Churg–Strauss syndrome. Arthritis Rheum 2010;62:627–34.
- Pagnoux C, Guillevin L. Cardiac involvement in small and medium-sized vessel vasculitides. Lupus 2005;14:718–22.
- Pela G, Tirabassi G, Pattoneri P, Pavone L, Garini G, Bruschi G. Cardiac involvement in the Churg–Strauss syndrome. Am J Cardiol 2006;97:1519–24.
- Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 2005;28:956–62.
- Bigger JT, Fleiss JL, Rolnitzky LM, Steinman RC. The ability of several short-term measures of RR variability to predict mortality after myocardial infarction. Circulation 1993;88:927–34.
- Guilpain P, Auclair JF, Tamby MC, Servettaz A, Mahr A, Weill B, Serum eosinophil cationic protein: a marker of disease activity in Churg–Strauss syndrome. Ann N Y Acad Sci 2007;1107:392–9.